Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 8:00 PM
Ignite Modification Date:
2025-12-24 @ 8:00 PM
NCT ID:
NCT02025504
Eligibility Criteria:
Inclusion Criteria:
* Male and female adults between the ages of 40 - 80
* Undergoing a colonoscopy at any of the study locations for:
i. CRC screening (first colonoscopy or 10 year follow up of negative exam). ii. Surveillance (prior colonoscopy with polyps). iii. Diagnostic colonoscopy performed to evaluate symptoms such as abdominal pain or rectal bleeding.
* Participants must have completed the full prescribed colonoscopy purgative preparation prior to their procedure, and describe adequate cleansing.
* For the purposes of informed consent, participants must be able to understand and read English.
Exclusion Criteria:
* Inability to provide informed consent
* Active or suspected pregnancy
* Patients referred due to incomplete colonoscopy or for removal of difficult polyps
* History of problems with sedation or anesthesia -. Participants electing to be unsedated for colonoscopy
* Patients undergoing multiple procedures (e.g. upper and lower endoscopy)
* Previous colon resection surgery
* Patients with known or suspected diagnosis of inflammatory bowel disease (ulcerative colitis or Crohn's disease)
* Patients with a history of colorectal cancer or other intra-abdominal malignancy.
* Patients with open or recent wounds or skin rash on the anterior abdominal wall.
* History of cirrhosis or ascites
* Known ventral or umbilical hernia
* Patients who are medically unstable(American Society of Anesthesiology Class III or above).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
80 Years
Study:
NCT02025504
Study Brief:
Protocol Section:
NCT02025504